Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis
Apitherapy with RJ + GP EPP-AF<sup>®</sup> extract significantly reduced plasma IL-6 and total cholesterol in HD patients. This supplementation shows promise as a non-pharmacological strategy to reduce cardiovascular risk markers in this population.
Authors
- Marcelo Ribeiro‐Alves (ORCID: https://orcid.org/0000-0002-8663-3364)
- Lia S. Nakao (ORCID: https://orcid.org/0000-0001-9647-6350)
- Manuel Mendonça
- Andresa Aparecida Berretta (ORCID: https://orcid.org/0000-0001-5719-1301)
- Denise Mafra (ORCID: https://orcid.org/0000-0001-6752-6056)
- Márcia Ribeiro (ORCID: https://orcid.org/0000-0002-4957-3630)
- Karen Salve Coutinho‐Wolino (ORCID: https://orcid.org/0000-0002-2489-1237)
- Eduardo Barbosa Coelho (ORCID: https://orcid.org/0000-0003-3491-3396)
- Fernanda Kussi (ORCID: https://orcid.org/0000-0001-7889-2748)
- Julie Ann Kemp (ORCID: https://orcid.org/0000-0001-6739-8832)
- L. Cardozo (ORCID: https://orcid.org/0000-0001-8507-2369)
- Isadora Britto (ORCID: https://orcid.org/0009-0009-0737-6127)
- Paloma Chrispim
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Federal Fluminense (BR)
- Universidade de São Paulo (BR)
- National Institute of Infectious Diseases (JP)
- Apis Flora (Brazil) (BR)
- Universidade Federal do Paraná (BR)
Publication Details
- Journal
- Toxins
- Published
- 2025-07-26
- DOI
- https://doi.org/10.3390/toxins17080369
- Citations
- 1
- Primary Topic
- Bee Products Chemical Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro